Michael D. Forrest

Cancer cells have distinct electrical properties that predict a susceptibility to lipophilic anions; a new cancer drug paradigm

The paper predicts cancer cells accumulate more lipophilic anions than normal cells based on charge number, suggesting a potential new drug paradigm targeting cancer cells selectively.

NADH as a cancer medicine

This paper proposes NADH as a potential cancer treatment with low side effects and oral administration, based on its metabolic properties and existing clinical trial clearance.